Correlation Between Serum Neuropeptide Y, Substance P, And 5-Ht Expression And Anxiety And Depression In Constipation-Predominant Irritable Bowel Syndrome Patients

Lianrong Guo,Yanying Zhao,Bin Liu
2018-01-01
Abstract:Objective: The aim of this study was to investigate the correlation of serum neuropeptide Y, substance P, and 5-hydroxytryptamine (5-HT) expression with anxiety and depression in patients with constipation-predominant irritable bowel syndrome (C-P IBS). Methods: Between January 2016 and May 2017, 68 patients with C-P IBS, diagnosed and treated in The Second Hospital of Shandong University, were enrolled in this study (observation group). Additionally, 68 concomitant healthy persons receiving physical examinations were enrolled as controls (control group). Serum neuropeptide Y, substance P, and 5-HT expression of all eligible participants were measured with application of Enzyme-linked immunosorbent assay (ELISA). Anxiety and depression of the two cohorts were evaluated using the Self-Rating Anxiety Scale (SAS) and Self-Rating Depression Scale (SDS). Any correlation of serum neuropeptide Y, substance P, and 5-HT expression with anxiety and depression were elucidated by Pearson's correlation analysis. Results: Compared to the control group, serum substance P expression of the observation group was significantly increased but serum neuropeptide Y and 5-HT expression were remarkably reduced in the observation group (all P<0.05). SAS and SDS scores in the observation group were also considerably higher (both P<0.05). Serum substance P levels in C-P IBS patients with anxiety and depression were strikingly higher, but serum neuropeptide Y and 5-HT levels were remarkably lower than those without anxiety and depression (all P<0.05). Among C-P IBS patients, there was a negative correlation of serum neuropeptide Y levels to SAS and SDS scores (r = -0.624, P = 0.012; r = -0.714; P = 0.005), positive correlation of serum substance P levels to SAS and SDS scores (r = 0.715, P = 0.002; r = 0.675, P = 0.007), and negative correlation of serum 5-HT levels to SAS and SDS scores (r = -0.784, P = 0.001; r = -0.762; P = 0.003). Conclusion: Neuroendocrine changes occurred in most C-P IBS patients. Abnormal levels of serum neuropeptide Y, substance P, and 5-HT might correlate with anxiety and depression in C-P IBS patients.
What problem does this paper attempt to address?